Boyce Sarahinsider trades

In SEC Form 4 filings, Boyce Sarah is listed as Director of Atrium Therapeutics, Inc. (RNA). Boyce Sarah reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 22.

Companies and roles

Company	Role	Transactions	Last filed
RNAAtrium Therapeutics, Inc.	Director	1	Sep 22

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-22

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RNAAtrium Therapeutics, Inc.	Sep 18	Sep 22	F	126,418	$8.95	$1,131,441	138,668	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.